Related Experiment Video
Updated: Jul 9, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Results of a two-year quality control program for a helical tomotherapy unit
Sara Broggi1, Giovanni Mauro Cattaneo, Silvia Molinelli
1Medical Physics, Scientific Institute San Raffaele, Milan, Italy. broggi.sara@hsr.it
Summary
This study confirms helical tomotherapy (HT) provides stable and reliable radiation therapy. Quality control over two years showed excellent mechanical and dosimetric performance, ensuring treatment accuracy.
Area of Science:
- Medical Physics
- Radiation Oncology
Background:
- Helical tomotherapy (HT) is an advanced intensity modulated radiation therapy (IMRT) technique using helical irradiation.
- HT integrates a rotating gantry, moving couch, and multileaf collimator (MLC) with integrated megavoltage CT (MVCT) for image guidance.
Purpose of the Study:
- To report the findings of a two-year quality control (QC) program for a helical tomotherapy unit.
- To assess the physical and dosimetric stability and reliability of the HT unit.
Main Methods:
- Adapted conventional linear accelerator (Linac) acceptance and QC protocols for HT.
- Evaluated mechanical-geometrical alignment, static and dynamic beam characteristics, gantry-couch-MLC synchronization, and MVCT image quality.
- Utilized ionization chambers, films, and phantoms for measurements.
Main Results:
- Average output variation was within +/-1% for static and rotational conditions, with 98% of data within action levels.
- Daily absolute dose verification showed dose reproducibility within +/-1.2% and +/-2.2% in low and high dose gradient regions.
- Mechanical alignment and positioning accuracy were within +/-1mm, and synchrony tests showed stability within +/-2mm.
Conclusions:
- The quality control program demonstrated good reproducibility for all mechanical and dosimetric performance aspects of the helical tomotherapy unit.
- The findings support the reliability and stability of HT for clinical radiation treatments.
